Comparing the current results to its competitors, Sanuwave Health Inc reported Revenue decrease in the 2 quarter 2026 year on year by -4.18 %, despite the revenue increase by the most of its competitors of 13.71 %, recorded in the same quarter.
Sanuwave Health Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 42.09 %
Sanuwave Health Inc 's Comment on Competition and Industry Peers
The Company operates in the market for low frequency and non-contact ultrasound and extracorporeal acoustic pressure shockwave technologies. It acquired assets related to the MIST Therapy System and UltraMIST System from Celularity Inc., which are used for wound treatment. The Company holds trademark registrations for SANUWAVE®, Energy First®, Healing Today, Curing Tomorrow®, UltraMIST®, Celleration®, and Proven Healing®. Its products compete with conventional wound care methods, including surgical or sharp debridement, standard wound dressings, compression therapy, and other established wound management practices. Competitive factors in the market include clinical outcomes, ease of use, patient comfort, reimbursement coverage, cost, and availability of supporting clinical evidence.
Microbot Medical Inc is a medical device company that focuses on the research, development, and commercialization of surgical solutions. Their business model revolves around creating innovative robotic technologies and tools for minimally invasive surgeries, catering to various medical specialties.
Myomo Inc's business model revolves around the development and commercialization of advanced medical devices, specifically myoelectric orthotics for individuals with neuromuscular disorders.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Align Technology Inc. employs a direct-to-consumer business model centered around its Invisalign clear aligners, which are marketed through licensed orthodontists and general practitioners. The company also operates a comprehensive digital platform that allows healthcare professionals to submit patient cases for treatment planning and to monitor patient progress throughout their orthodontic journey.
Vycor Medical Inc has a business model focused on developing and commercializing innovative medical devices and technologies in the healthcare industry.
Sources:
Sanuwave Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sanuwave Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
